Profil
Gina M.
Wallar worked as a Director at LabCorp Clinical Trials.
She then worked at NeoGenomics, Inc. as the President-Pharma Services Division from 2021 to 2022.
Dr. Wallar holds a doctorate degree from the University of California, Los Angeles.
Anciens postes connus de Gina M. Wallar
| Sociétés | Poste | Fin |
|---|---|---|
| NEOGENOMICS, INC. | Corporate Officer/Principal | 27/05/2022 |
Labcorp Clinical Trials
 Labcorp Clinical Trials Hospital/Nursing ManagementHealth Services Labcorp Clinical Trials provides healthcare services. The company is headquartered in Hamburg, Germany. | Director/Board Member | - |
Formation de Gina M. Wallar
| University of California, Los Angeles | Doctorate Degree |
Expériences
Fonctions occupées
Relations
34
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NEOGENOMICS, INC. | Health Services |
| Entreprise privées | 1 |
|---|---|
Labcorp Clinical Trials
Labcorp Clinical Trials Hospital/Nursing ManagementHealth Services Labcorp Clinical Trials provides healthcare services. The company is headquartered in Hamburg, Germany. | Health Services |
